Edesa Biotech Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Edesa Biotech Stock Forecast and Price Target
If the average price target of $21.00 set by distinguished experts for Edesa Biotech over the past few weeks is reached this year, there would be a potential upside of approximately 371.91% from the last closing price in May, 2024. This potential increase is based on a high estimate of $32.00 and a low estimate of $19.00.
371.91% Upside
Edesa Biotech Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Edesa Biotech's Price has grown, increasing from $0.00 to $0.00 – an increase of 100.00%. For next year, the 0 analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next six years, the pros' prediction is Fair Valueof $0.00, which would mean a six-year growth forecast of 100.00%.
.jpg)
Edesa Biotech EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Edesa Biotech's EBITDA has grown by 43.62%, from $-6.35M to $-9.12M. For the next year, analysts are expecting EBITDA to reach $-10.83M – an increase of 18.75%. Over the next seven years, experts predict that EBITDA will grow by 67.56%.
Edesa Biotech EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Edesa Biotech's EBIT has grown from $-6.40M to $-9.22M – a 44.06% increase. Next year, analysts are expecting EBIT to reach $-10.92M – an increase of 18.39%. Over the next seven years, the forecast is for EBIT to grow by 66.62%.
Edesa Biotech EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Edesa Biotech's EPS has grown, increasing from $-5.18 to $0.00 – an increase of 100.00%. For next year, the 0 analysts predict EPS of $0.00, which would mean an increase of 100.00%. Over the next six years, the pros' prediction is EPSof $0.00, which would mean a six-year growth forecast of 100.00%.
.jpg)